Home Cart 0 Sign in  
X

[ CAS No. 21203-68-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 21203-68-9
Chemical Structure| 21203-68-9
Chemical Structure| 21203-68-9
Structure of 21203-68-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 21203-68-9 ]

Related Doc. of [ 21203-68-9 ]

Alternatived Products of [ 21203-68-9 ]

Product Details of [ 21203-68-9 ]

CAS No. :21203-68-9 MDL No. :MFCD04114179
Formula : C6H6N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :USZINSZJSVMICC-UHFFFAOYSA-N
M.W : 138.12 Pubchem ID :2794552
Synonyms :

Calculated chemistry of [ 21203-68-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 38.02
TPSA : 58.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.44 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.2
Log Po/w (XLOGP3) : 0.99
Log Po/w (WLOGP) : 1.3
Log Po/w (MLOGP) : 0.41
Log Po/w (SILICOS-IT) : -0.35
Consensus Log Po/w : 0.71

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.7
Solubility : 2.77 mg/ml ; 0.02 mol/l
Class : Very soluble
Log S (Ali) : -1.81
Solubility : 2.13 mg/ml ; 0.0154 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.76
Solubility : 2.38 mg/ml ; 0.0172 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 21203-68-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 21203-68-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 21203-68-9 ]
  • Downstream synthetic route of [ 21203-68-9 ]

[ 21203-68-9 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 21203-68-9 ]
  • [ 2364-75-2 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 22, p. 6102 - 6105
  • 2
  • [ 109-06-8 ]
  • [ 21203-68-9 ]
  • [ 18699-87-1 ]
YieldReaction ConditionsOperation in experiment
0.1 g With oxygen; nitrogen(II) oxide In acetonitrile at 90℃; for 10 h; Into the reactor, 0.93 g (10.0 mmol) of 2-methylpyridine, 5 mL of acetonitrile, 0.15 g of sulfonated graphene was added, and the reaction was stirred under an oxygen atmosphere at 5.0 MPa of nitrogen monoxide and a temperature of 90 ° C for 10 h. After the end of the reaction, nitrogen gas was introduced into the reaction mixture at a normal pressure until the nitrogen oxides completely escaped to the cold trap reaction receiver, and the catalyst was filtered off. The filtrate was washed with a 5percent (m/m) aqueous solution of sodium hydrogencarbonate to near neutral, and then washed with distilled water until the organic phase was neutral and concentrated by evaporation in vacuo. Separating the product components by column chromatography,The mass of 2-methylnitropyridine is 0.67g,Wherein 2-methyl-3-nitropyridine 0.10 g (mass fraction 16percent),2-methyl-5-nitropyridine 0.57 g (mass fraction 84percent), yield 49percent.
Reference: [1] Acta Chemica Scandinavica, 1994, vol. 48, # 2, p. 181 - 182
[2] Acta Chemica Scandinavica, 1994, vol. 48, # 12, p. 1001 - 1006
[3] Patent: CN108003029, 2018, A, . Location in patent: Paragraph 0043; 0044
  • 3
  • [ 659742-21-9 ]
  • [ 109-06-8 ]
  • [ 21203-68-9 ]
  • [ 18699-87-1 ]
  • [ 57927-99-8 ]
Reference: [1] Journal of Organic Chemistry, 2012, vol. 77, # 9, p. 4402 - 4413
  • 4
  • [ 21203-68-9 ]
  • [ 35969-75-6 ]
YieldReaction ConditionsOperation in experiment
94% With selenium(IV) oxide In 1,4-dioxane for 16 h; Reflux To a stirred solution of 2-methyl-5-nitropyridine (3.0 g, 0.021 mol, 1 eq) in 1 ,4- dioxane (30 mL) at room temperature was added selenium dioxide (2.9 g, 0.026 mol, 1.2 eq) and stirred at reflux for 16 h. The reaction mixture was filtered, evaporated, diluted with ethyl acetate (50 mL) and washed with water (50 mL), dried over sodium sulphate and evaporated to get 5-nitropicolinaldehyde (3.12g, 94 percent).
94% With selenium(IV) oxide In 1,4-dioxane for 16 h; Reflux Step 1
To a stirred solution of 2-methyl-5-nitropyridine (3.0 g, 0.021 mol, 1 eq) in 1,4-dioxane (30 mL) at room temperature was added selenium dioxide (2.9 g, 0.026 mol, 1.2 eq) and stirred at reflux for 16 h.
The reaction mixture was filtered, evaporated, diluted with ethyl acetate (50 mL) and washed with water (50 mL), dried over sodium sulfate and evaporated to get 5-nitropicolinaldehyde (3.12 g, 94percent).
35%
Stage #1: With selenium(IV) oxide; water In 1,4-dioxane for 4 h; Heating / reflux
Stage #2: With sodium hydrogencarbonate In 1,4-dioxane; diethyl ether; water
A mixture of 2-methyl-5-nitropyridine (3 g), selenium (IV) (2.9 g), 1,4- dioxane (25 mL) and water (0.5 mL) was refluxed for 4 hrs. The resulting black solid was filtered through Celite° bed and washed with ether. The filtrate was treated with saturate aqueous NaHC03 and filtered again. The filtrate was extracted with ether twice and the solvent was concentrated. The residue was purified with a short silica gel column eluted with 20percent ethyl acetate in hexane to give 1.0 g of orange precipitate 2 (35percent yield). 1H NMR (CD2Cl2): 8 10.15 (s, 1H), 9.55 (s, 1H), 8.7 (d, 1H), 8.15 (s, 1H).
Reference: [1] Patent: WO2013/13815, 2013, A1, . Location in patent: Page/Page column 230; 231
[2] Patent: US2013/29962, 2013, A1, . Location in patent: Paragraph 1110
[3] Journal of Organic Chemistry, 2012, vol. 77, # 20, p. 8968 - 8979,12
[4] Journal of Medicinal Chemistry, 1992, vol. 35, # 20, p. 3672 - 3677
[5] Patent: WO2005/97752, 2005, A1, . Location in patent: Page/Page column 42
[6] Journal of Organic Chemistry, 1959, vol. 24, p. 1007
[7] Bulletin of the Chemical Society of Japan, 1993, vol. 66, # 3, p. 797 - 803
  • 5
  • [ 21203-68-9 ]
  • [ 119830-47-6 ]
Reference: [1] Journal of Organic Chemistry, 1984, vol. 49, # 20, p. 3681 - 3684
  • 6
  • [ 56057-19-3 ]
  • [ 21203-68-9 ]
  • [ 39745-39-6 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 596,598
  • 7
  • [ 21203-68-9 ]
  • [ 30651-24-2 ]
Reference: [1] Journal of Organic Chemistry, 1984, vol. 49, # 20, p. 3681 - 3684
[2] Journal of Heterocyclic Chemistry, 2005, vol. 42, # 2, p. 259 - 264
[3] Journal of the American Chemical Society, 1954, vol. 76, p. 3167
  • 8
  • [ 21203-68-9 ]
  • [ 30563-98-5 ]
Reference: [1] Journal of Organic Chemistry, 1984, vol. 49, # 20, p. 3681 - 3684
  • 9
  • [ 21203-68-9 ]
  • [ 36625-57-7 ]
Reference: [1] Patent: WO2013/13815, 2013, A1,
[2] Patent: US2013/29962, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 21203-68-9 ]

Nitroes

Chemical Structure| 36625-57-7

[ 36625-57-7 ]

(5-Nitropyridin-2-yl)methanol

Similarity: 0.91

Chemical Structure| 35969-75-6

[ 35969-75-6 ]

5-Nitropicolinaldehyde

Similarity: 0.89

Chemical Structure| 1074-99-3

[ 1074-99-3 ]

2,4-Dimethyl-5-nitropyridine

Similarity: 0.88

Chemical Structure| 84531-36-2

[ 84531-36-2 ]

3-Nitro-6,7-dihydro-5H-cyclopenta[b]pyridine

Similarity: 0.86

Chemical Structure| 2229221-49-0

[ 2229221-49-0 ]

2-(2-Bromoethyl)-5-nitropyridine

Similarity: 0.86

Related Parent Nucleus of
[ 21203-68-9 ]

Pyridines

Chemical Structure| 36625-57-7

[ 36625-57-7 ]

(5-Nitropyridin-2-yl)methanol

Similarity: 0.91

Chemical Structure| 35969-75-6

[ 35969-75-6 ]

5-Nitropicolinaldehyde

Similarity: 0.89

Chemical Structure| 1074-99-3

[ 1074-99-3 ]

2,4-Dimethyl-5-nitropyridine

Similarity: 0.88

Chemical Structure| 51984-61-3

[ 51984-61-3 ]

2-Methyl-5-nitropyridin-3-amine

Similarity: 0.86

Chemical Structure| 2229221-49-0

[ 2229221-49-0 ]

2-(2-Bromoethyl)-5-nitropyridine

Similarity: 0.86